Response to combination antiretroviral therapy: variation by age
Authors:
- Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study GroupCGCollaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group
- Caroline A SabinCSCaroline A Sabin
- Colette J SmithCSColette J Smith
- Antonella D'Arminio MonforteAMAntonella D'Arminio Monforte
- Manuel BattegayMBManuel Battegay
- Clara GabianoCGClara Gabiano
- Luisa GalliLGLuisa Galli
- Sibyl GeelenSGSibyl Geelen
- Diana GibbDGDiana Gibb
- Marguerite GuiguetMGMarguerite Guiguet
- Ali JuddAJAli Judd
- Catherine LeportCLCatherine Leport
- 31 July 2008
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 22 (12) , 1463-1473
Abstract
To provide information on responses to combination antiretroviral therapy in children, adolescents and older HIV-infected persons. Multicohort collaboration of 33 European cohorts. : Forty-nine thousand nine hundred and twenty-one antiretroviral-naive individuals starting combination antiretroviral therapy from 1998 to 2006. Time from combination antiretroviral therapy initiation to HIV RNA less than 50 copies/ml (virological response), CD4 increase of more than 100 cells/microl (immunological response) and new AIDS/death were analysed using survival methods. Ten age strata were chosen: less than 2, 2-5, 6-12, 13-17, 18-29, 30-39 (reference group), 40-49, 50-54, 55-59 and 60 years or older; those aged 6 years or more were included in multivariable analyses. The four youngest age groups had 223, 184, 219 and 201 individuals and the three oldest age groups had 2693, 1656 and 1613 individuals. Precombination antiretroviral therapy CD4 cell counts were highest in young children and declined with age. By 12 months, 53.7% (95% confidence interval: 53.2-54.1%) and 59.2% (58.7-59.6%) had experienced a virological and immunological response. The probability of virological response was lower in those aged 6-12 (adjusted hazard ratio: 0.87) and 13-17 (0.78) years, but was higher in those aged 50-54 (1.24), 55-59 (1.24) and at least 60 (1.18) years. The probability of immunological response was higher in children and younger adults and reduced in those 60 years or older. Those aged 55-59 and 60 years or older had poorer clinical outcomes after adjusting for the latest CD4 cell count. Better virological responses but poorer immunological responses in older individuals, together with low precombination antiretroviral therapy CD4 cell counts, may place this group at increased clinical risk. The poorer virological responses in children may increase the likelihood of emergence of resistance.Keywords
This publication has 39 references indexed in Scilit:
- Current CD4 Cell Count and the Short‐Term Risk of AIDS and Death before the Availability of Effective Antiretroviral Therapy in HIV‐Infected Children and AdultsThe Journal of Infectious Diseases, 2008
- Underdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997-2005: cohort studyBMJ, 2006
- Determinants of clinical progression in antiretroviral‐naïve HIV‐infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996–2002HIV Medicine, 2005
- PENTA guidelines for the use of antiretroviral therapy, 2004HIV Medicine, 2004
- Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA studyHIV Medicine, 2003
- Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patientsAIDS, 2002
- Increased Thymic Output after Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus Type 1–Infected Children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 TrialThe Journal of Infectious Diseases, 2002
- Clinical, Biologic, and Behavioral Predictors of Early Immunologic and Virologic Response in HIV-Infected Patients Initiating Protease InhibitorsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Prognostic Factors of Combined Viral Load and CD4+ Cell Count Responses Under Triple Antiretroviral Therapy, Aquitaine Cohort, 1996–1998JAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Age‐related reference ranges: Significance tests for models and confidence intervals for centilesStatistics in Medicine, 1994